{
}
UBS has downgraded Zurich Insurance Group Ltd to a Sell rating. The company's income distribution is primarily from general insurance (75.2%), followed by life insurance (19.6%), with a small portion from other services (0.7%) and Farmers Group activities (4.5%).
Zurich Insurance Group Ltd has been downgraded to a "sell" rating by UBS. The company's revenue is primarily derived from general insurance (75.2%), followed by life insurance (19.6%), with a small portion from other activities (0.7%) and services from the Farmers Group (4.5%).
Zurich Insurance Group's shares declined after UBS downgraded the stock to "sell" from "neutral," citing concerns over valuation, debt leverage, and interest rate sensitivity. The downgrade highlights that shares are trading at a 30% premium to their five-year average P/E ratio, with limited room for appreciation. UBS also noted that Zurich's reliance on commercial lines, which make up 75% of its business, could hinder profitability as pricing lags inflation, while higher debt levels may restrict shareholder returns.
Zurich Insurance Group's shares declined after UBS downgraded the stock from "neutral" to "sell," citing concerns over valuation, debt leverage, and interest rate sensitivity. The stock is trading at a 30% premium to its five-year average P/E ratio, limiting further appreciation potential. UBS also reduced its price target by 3% to CHF 515, highlighting risks associated with the company's reliance on commercial lines and projected earnings growth that may not materialize.
Zurich Insurance Group's shares declined after UBS downgraded the stock from "neutral" to "sell," citing concerns over overvaluation, debt leverage, and interest rate sensitivity. The stock is trading at a 30% premium to its five-year average P/E ratio, with UBS reducing its price target by 3% to CHF 515. Analysts highlighted the company's heavy reliance on commercial lines, which may struggle to keep pace with inflation, potentially impacting profitability.
Zurich Insurance Group's shares declined after UBS downgraded the stock to "sell" from "neutral," citing concerns over valuation, debt leverage, and interest rate sensitivity. The stock is trading at a 30% premium to its five-year average P/E ratio, limiting further appreciation potential. UBS also highlighted the company's heavy reliance on commercial lines, which may struggle to keep pace with inflation, impacting profitability.
UBS has downgraded Zurich Insurance to a "sell" rating from "neutral," reducing its target price to 515 Swiss francs from 532 Swiss francs. The analyst cites limited growth potential and a fully reflected share price in light of the company's three-year plan, despite a forecast of over 9% average annual growth in core EPS for 2025-2027.
UBS has downgraded Zurich Insurance to a sell rating, reducing the target price from 532 to 515 Swiss francs. The analyst notes that the current share price reflects the company's three-year plan, indicating limited earnings growth potential and a risk of valuation contraction. Zurich has set a target for over 9% average annual growth in core earnings per share from 2025 to 2027.
UBS has downgraded Zurich Insurance Group from "Neutral" to "Sell," reducing its price target from 532 to 515 Swiss francs. Analyst Will Hardcastle noted that the company's valuation is high compared to its historical performance and the European insurance sector, indicating potential correction risks.
UBS has shifted its stance on Zurich Insurance Group Ltd from neutral to short. The company generates its revenues primarily from general insurance (75.2%), followed by life insurance (19.6%), with a small portion from other activities (0.7%) and services from the Farmers Group (4.5%).
Zurich Insurance Group AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs downgrades zurich insurance group to sell rating
05:54 20.12.2024
ubs downgrades zurich insurance group to sell amid revenue concerns
05:54 20.12.2024
ubs downgrades zurich insurance shares to sell amid valuation concerns
11:40 19.12.2024
ubs downgrades zurich insurance shares to sell amid valuation concerns
11:40 19.12.2024
Zurich Insurance shares decline after UBS downgrades to sell rating
11:38 19.12.2024
ubs downgrades zurich insurance shares to sell amid valuation concerns
11:38 19.12.2024
ubs downgrades zurich insurance to sell amid limited growth prospects
10:40 19.12.2024
ubs downgrades zurich insurance to sell amid limited growth prospects
10:35 19.12.2024
UBS downgrades Zurich Insurance Group to sell with reduced price target
08:02 19.12.2024
ubs changes stance on zurich insurance group to short position
07:49 19.12.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Industry Trends
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
Supply Chain Management
Private Equity Deals
Inflation and Monetary Impact
Government Economic Policies
Retail and Consumer Goods
Cryptocurrency Trends
Venture Capital Investments
Fintech Startups
Workplace Trends
CEO Changes
Central Bank Actions
Central Banks and Digital Currencies
Finance Mergers & Acquisitions
Energy Sector Developments
Countries:
Companies:
Apple Inc.
Google Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Tesla, Inc.
Tencent Holdings Ltd
NIO Inc.
Nikkei 225
Nintendo Co., Ltd.
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Currencies:
United States Dollar
Indian Rupee
Euro
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
Egyptian Pound
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
South Korean Won
Thai Baht
Mexican Peso
Croatian Kuna
Bahraini Dinar
People: